An intrepid solution for transfemoral treatment of mitral regurgitation

Sponsored by Medtronic

Anchorperson: A. Duncan
SHOW MORE

Summary

In this session, get insights into the APOLLO EU trial and its current progress, obtain a comprehensive understanding of the latest data from the Early Feasibility TF trial, and discern which patients stand to benefit the most from this treatment.

Learning Objectives

  • To learn more about the APOLLO EU trial and journey to date
  • To understand the latest data on the Early Feasibility TF trial
  • To understand which patients can best benefit from this treatment